KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Asset Writedowns and Impairment (2016 - 2026)

Medtronic's Asset Writedowns and Impairment history spans 13 years, with the latest figure at $36.0 million for Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment fell 29.41% to $36.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was $129.0 million, a 68.15% decrease, with the full-year FY2025 number at $123.0 million, down 66.85% from a year prior.
  • Asset Writedowns and Impairment hit $36.0 million in Q1 2026 for Medtronic, down from $38.0 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for MDT hit a ceiling of $466.0 million in Q2 2022 and a floor of -$466.0 million in Q1 2022.
  • Historically, Asset Writedowns and Impairment has averaged $39.4 million across 5 years, with a median of $26.0 million in 2022.
  • The widest YoY moves for Asset Writedowns and Impairment: up 1764.0% in 2022, down 552.43% in 2022.
  • Tracing MDT's Asset Writedowns and Impairment over 5 years: stood at $26.0 million in 2022, then crashed by 38.46% to $16.0 million in 2023, then soared by 68.75% to $27.0 million in 2024, then soared by 40.74% to $38.0 million in 2025, then dropped by 5.26% to $36.0 million in 2026.
  • Business Quant data shows Asset Writedowns and Impairment for MDT at $36.0 million in Q1 2026, $38.0 million in Q4 2025, and $28.0 million in Q3 2025.